Search results
FDA, doctors warn about compounded Ozempic. What we found at metro weight loss clinics
WFXT via Yahoo News· 4 hours agoIt’s a popular drug that millions of people are taking to lose weight, but the federal government...
FDA approves Libervant for young epilepsy patients By Investing.com
Investing.com· 7 hours agoAquestive Therapeutics , Inc. (NASDAQ: NASDAQ:AQST) announced that the U.S. Food and Drug...
Neurocrine bags FDA approval for new ‘sprinkle’ Ingrezza formulation
Pharmaceutical Technology via Yahoo Finance· 11 hours agoThe US Food and Drug Administration (FDA) has approved an alternative formulation for Neurocrine...
FDA approves asthma drug for treating food allergies
WOOD via Yahoo News· 6 days agoA drug newly approved by the Food and Drug Administration to reduce the risk of allergic reactions from food could bring relief to millions across the...
FDA Issues Final Rule Regulating Many Laboratory-Developed Tests as Medical Devices
The National Law Review· 11 hours agoOn April 29, 2024, the US Food and Drug Administration (FDA) issued the long-awaited final rule...
FDA approves Neurocrine Biosciences' Huntington's disease drug
Reuters via Yahoo Finance· 1 day agoApril 30 (Reuters) - The U.S. Food and Drug Administration (FDA) has approved granule formulation of Neurocrine Biosciences'
Wegovy & other GLP-1 drugs to get coverage under Medicare Part D
AARP· 10 hours agoThe FDA recently approved a new use for Wegovy (semaglutide), the blockbuster anti-obesity drug, to reduce the risk of heart attacks ...
Bird flu virus test results are in: Cottage cheese and sour cream are safe, FDA says
Fast Company Magazine· 8 hours agoThe U.S. Food and Drug Administration said on Wednesday that preliminary results of additional...
Neurocrine Biosciences’ Huntington’s disease drug gets FDA approval
WHTC 1450 Holland· 1 day agoBy Sruthi Narasimha Chari (Reuters) -The U.S. Food and Drug Administration (FDA) has approved the granule formulation of Neurocrine Biosciences ...
FDA approves first targeted therapy for WHIM syndrome By Investing.com
Investing.com· 3 days agoX4 Pharmaceuticals (NASDAQ:XFOR) announced today the U.S. Food and Drug Administration (FDA) has ...